Saturday, July 11, 2026

pharma · Clear Cell Renal Cell Carcinoma · Cushing s Syndrome

Peking University Biologics

Peking University Biologics clinical programs — 1 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

仙霞路, 319号, 上海市, 长宁区, CN HQ
2018 Founded
8 Employees
NMPA registrant Type
Company details
Status
Public
HQ
仙霞路, 319号, 上海市, 长宁区, CN
Founded
2018
Employees
8
Programs
15
Drugs
25
Patents
0
Intelligence · Clinical Programs

Peking University Biologics projects

1 ClinicalTrials.gov programs sponsored by Peking University Biologics.

Peking University Biologics has 1 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. Triptolide Wilfordii

    Peking University Third Hospital

    HIV-infection/AIDS

    phase 3 small molecule completed

    1 trial

Frequently asked questions

How many clinical projects does Peking University Biologics have?

1 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.